Analysis of Indoleamine 2-3 Dioxygenase (IDO) and EGFR Co-expression in Breast Cancer Tissue by Immunohistochemistry |
Bi, Wei-Wei
(Department of Biological Engineering College of Pharmacy Jilin University)
Zhang, Wei-Hua (Siping Hospital of China Medical University) Yin, Gui-Hua (Siping Hospital of China Medical University) Luo, Hong (Siping Hospital of China Medical University) Wang, Shou-Qin (Siping Hospital of China Medical University) Wang, Hongran (Department of Molecular and Cellular Biology, Baylor College of Medicine) Li, Chao (TuoHua Biological Technology Company) Yan, Wei-Qun (Department of Biological Engineering College of Pharmacy Jilin University) Nie, De-Zhi (TuoHua Biological Technology Company) |
1 | Tan DS, Marchio C, Jones RL, et al (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Tr, 111, 27-44. DOI ScienceOn |
2 | Tong L, Yang XX, Liu MF, et al (2012). Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients. Asian Pac J Cancer Prev, 13, 5599-603. 과학기술학회마을 DOI ScienceOn |
3 | Van der Loos CM, Das PK, Houthoff HJ (1987). An immunoenzyme triple-staining method using both polyclonal and monoclonal antibodies from the samespecies. Application of combined direct, indirect, and avidin-biotin complex (ABC) technique. J Histochem Cytochem, 35, 1199-204. DOI |
4 | Van Noorden S, Stuart MC, Cheung A, et al (1986). Localization of human pituitary hormones by multiple immunoenzyme staining procedures using monoclonal andpolyclonal antibodies. J Histochem Cytochem, 34, 287-92. DOI |
5 | Arteaga C (2003). Targeting HER1/EGFR: a molecular approach to cancer therapy. Semin Oncol, 30, 3-14. DOI |
6 | Hu Q, Luo Z , Xu T, et al (2014). FOXA1: a promising prognostic marker in breast cancer. Asian Pac J Cancer Prev, 15, 11-6. 과학기술학회마을 DOI |
7 | Abediankenari S, Jeivad F (2013). Epidermal growth factor receptor gene polymorphisms and gastric cancer in Iran. Asian Pac J Cancer Prev, 14, 3187-90. 과학기술학회마을 DOI |
8 | Brandacher G , Perathoner A, Ladurner R, et al (2006). Prognostic value of indoleamine 2, 3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res, 12, 1144-51. DOI |
9 | Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76. DOI ScienceOn |
10 | Ino K, Yoshida N, Kajiyama H, et al (2006). Indoleamine 2, 3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer, 95, 1555-61. DOI |
11 | Kim H, Choi DH, Park W, et al (2013). Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J, 31, 222-7. DOI |
12 | Mansfield AS, Heikkila PS, Vaara AT, et al (2009). Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer, 15, 231. |
13 | Okamoto H, Fujishima F, Nakamura Y, et al (2013). Significance of CD133 expression in esophageal squamous cell carcinoma. World J Surg Oncol, 11, 51. DOI |
14 | Rakha EA, Elsheikh SE, Aleskandarany MA, et al (2009). Triplenegative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res, 15, 2302-10. DOI ScienceOn |
![]() |